Combination of Bortezomib, Fludarabine and Cyclophosphamide Treat Recurrent Mantle Cell Lymphoma
Clinical trial NCT01322776 · UNKNOWN
Trial details
- NCT number
- NCT01322776
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2013-10-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.